SlideShare a Scribd company logo
The HIV cascade
Laura Waters
Mortimer Market Centre
CNWL NHS Trust
What are cascades?
• A broad overview of how well a given condition is
managed
• Trials and many observational studies focus on
treatment outcomes, excluding those untreated or
undiagnosed
• “95% of people treated for condition X had good
outcomes”
• Cascades show the whole picture and where the
gaps are….
Cascade of care for condition X
60% 58% 56%
50%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
With condition Diagnosed In care Treated Optimally
treated
100%
Cascade of care for condition Y
90%
50%
40%
35%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
With condition Diagnosed In care Treated Optimally
treated
100%
UK cascade of HIV care 2014
83%
75%
70%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
HIV-infected Diagnosed On ART Undetectable VL
Based on 1.2 million people living with HIV
Delpech V at al. Abstract O2; BHIVA conference April 20-22 2016.
USA: continuum of care 2011
86%
40%
37%
30%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Diagnosed In care Prescribed ART Virally suppressed
https://www.aids.gov/federal-resources/policies/care-continuum/
Based on 1.2 million people living with HIV
USA cascade of hypertension:
69.8m of 227.6m hypertensive
94%
78%
73%
50%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Hypertensive Source of care Aware Treated Controlled
100%
Wozniak G et al. J Clin Hypertens (Greenwich). 2016 Mar;18(3):232-9.
Cascades can also be….
• Aspirational!
• The basis of public health interventions….
What is 90-90-90?
• December 2013:
– The UNAIDS Programme Coordinating Board called on
UNAIDS to establish new targets for HIV treatment scale-
up beyond 2015
• The following goals were agreed in 2014:
– By 2020, 90% of all people living with HIV will know their
HIV status.
– By 2020, 90% of all people with diagnosed HIV infection
will receive sustained antiretroviral therapy.
– By 2020, 90% of all people receiving antiretroviral therapy
will have viral suppression.
90-90-90
73%
What does that mean?
• 73% of all PLWH on suppressive ART would be a 2-3
fold increase compared with 2014 estimates
• Modelling suggests that achieving these targets by
2020 will end the AIDS epidemic by 2030
Ref: The Joint United Nations Programme on HIV/AIDS. 90-90-90 An ambitious treatment target to help end the AIDS epidemic. 2014; JC2684
(Numbers as of March 2015) How Aids Changed Everything. Fact Sheet. UNAIDS 2015. MDG 6: 15 YEARS, 15 LESSONS OF HOPE FROM THE AIDS
RESPONSE July 2015.
Target 1:
90% of HIV+ people
diagnosed
Target 2:
90% of diagnosed
people on ART
Target 3:
90% of people on
ART with HIV
RNA suppression90%
81%
73%
0%
20%
40%
60%
80%
100%
HIV Positive People Diagnosed On ART Viral Suppression
36.9
million
33.2
million 29.5
million 26.9
million
UNAIDS 90-90-90: HIV Treatment Targets
for 2020 with Global Estimates (2014)
53%
41%
32%*
0%
20%
40%
60%
80%
100%
HIV Positive People Diagnosed On ART Viral Suppression <1000
(ITT)*
36.9
million
19.8
million
15.0
million
11.6*
million
Ref: On ART = March 2015. How Aids Changed Everything. Fact Sheet. UNAIDS 2015. MDG 6: 15 YEARS, 15 LESSONS OF HOPE FROM THE AIDS
RESPONSE July 2015. * Average viral suppression% Intention to Treat LMIC rate from a Systematic Review by McMahon J. et al. Viral suppression
after 12 months of antiretroviral therapy in low-and middle-income countries: a systematic review." Bulletin of the World Health Organization 91.5
(2013): 377-385.
Breakpoint 1:
13.4 million
Undiagnosed Breakpoint 2:
14.9 million
not treated
Breakpoint 3:
15.3 million
Not Virally
Supressed
Global Estimates (2014-15) vs the Gap
to reach 90-90-90 Targets
UNAIDS: 90-90-90
90%90%
90%
90% 90%
UNAIDS. 90–90–90: an ambitious treatment target to help end the AIDS epidemic. 2014.
http://www.unaids.org/sites/default/files/media_asset/90-90-90_en_0.pdf. Accessed 29th June 2016
Diagnosed On treatment Undetectable What about
those on ART
& ‘stable’??
?
May 2016:
World Health Assembly’s 69th session
• Approved a new Global Health Sector Strategy on
HIV for 2016–2021
• Goal is “to end the AIDS epidemic as a public health
threat by 2030”
“zero new HIV infections, zero HIV-related deaths and zero HIV-
related discrimination in a world where people living with HIV
are able to live long and healthy lives”
“to end the AIDS epidemic as a public health threat by 2030,
within the context of ensuring healthy lives and promoting
well-being for all at all ages”
World Health Organization. Draft global health sector strategy on HIV, 2016–2021 [Draft 01.12.2015]. 2015.
http://apps.who.int/gb/ebwha/pdf_files/WHA69/A69_31-en.pdf?ua=1. Acceessed 29th June 2016
UNAIDS: 90-90-90-90?
90%90%
90%
90% 90% 90%
Lazarus JV et al. BMC Med. 2016; 14: 94. Adapted from UNAIDS. 90–90–90: an ambitious treatment target to help end the AIDS epidemic. 2014.
http://www.unaids.org/sites/default/files/media_asset/90-90-90_en_0.pdf. Accessed 29th June 2016
Diagnosed On treatment Undetectable Good health-
related QoL
Thank you!
?lwaters@nhs.net
@drlaurajwaters

More Related Content

What's hot

Addressing the second 90: How can treatment scale-up across the European regi...
Addressing the second 90: How can treatment scale-up across the European regi...Addressing the second 90: How can treatment scale-up across the European regi...
Addressing the second 90: How can treatment scale-up across the European regi...
European Centre for Disease Prevention and Control
 
Priorities for fast tracking the end of AIDS in Europe: Community perspective
Priorities for fast tracking the end of AIDS in Europe: Community perspectivePriorities for fast tracking the end of AIDS in Europe: Community perspective
Priorities for fast tracking the end of AIDS in Europe: Community perspective
European Centre for Disease Prevention and Control
 
What is HIV epidemic control?
What is HIV epidemic control?What is HIV epidemic control?
What is HIV epidemic control?
Albert Mwango
 
Onile-ere et al 2016
Onile-ere et al 2016Onile-ere et al 2016
Onile-ere et al 2016
Olabode Onile-ere
 
What is epidemic control after 2020 mwango 04082021
What is epidemic control after 2020 mwango 04082021What is epidemic control after 2020 mwango 04082021
What is epidemic control after 2020 mwango 04082021
Albert Mwango
 
01 viral load testing in zambia
01 viral load testing in zambia01 viral load testing in zambia
01 viral load testing in zambia
Albert Mwango
 
Bacterial Adaptive immunity, Gene drives and the genetic control of Malaria
Bacterial Adaptive immunity, Gene drives and the genetic control of MalariaBacterial Adaptive immunity, Gene drives and the genetic control of Malaria
Bacterial Adaptive immunity, Gene drives and the genetic control of Malaria
Olabode Onile-ere
 
HIV self-testing and linkage in Africa
HIV self-testing and linkage in AfricaHIV self-testing and linkage in Africa
HIV self-testing and linkage in Africa
Cheryl Johnson
 
David curry
David curryDavid curry
David curry
Rosella Anstine
 
APCRSHR10 Virtual Abstract Presentation of Dr Moazzam Ali
APCRSHR10 Virtual Abstract Presentation of Dr Moazzam AliAPCRSHR10 Virtual Abstract Presentation of Dr Moazzam Ali
APCRSHR10 Virtual Abstract Presentation of Dr Moazzam Ali
CNS www.citizen-news.org
 
Reaching the Millennial Generation about HIV/AIDS
Reaching the Millennial Generation about HIV/AIDSReaching the Millennial Generation about HIV/AIDS
Reaching the Millennial Generation about HIV/AIDS
YTH
 
03 children's enhanced adherence couselling in zambia ss
03 children's enhanced adherence couselling in zambia ss03 children's enhanced adherence couselling in zambia ss
03 children's enhanced adherence couselling in zambia ss
Albert Mwango
 
Evaluation of the Impact of Malaria Control Interventions on All-Cause Mortal...
Evaluation of the Impact of Malaria Control Interventions on All-Cause Mortal...Evaluation of the Impact of Malaria Control Interventions on All-Cause Mortal...
Evaluation of the Impact of Malaria Control Interventions on All-Cause Mortal...
MEASURE Evaluation
 
AIRAPertussisUTD_20150422
AIRAPertussisUTD_20150422AIRAPertussisUTD_20150422
AIRAPertussisUTD_20150422
Lauren Snyder
 
02 efficacious arv regimens for children in zambia
02 efficacious arv regimens for children in zambia02 efficacious arv regimens for children in zambia
02 efficacious arv regimens for children in zambia
Albert Mwango
 
Dynamic Talks: "Applications of Big Data, Machine Learning and Artificial Int...
Dynamic Talks: "Applications of Big Data, Machine Learning and Artificial Int...Dynamic Talks: "Applications of Big Data, Machine Learning and Artificial Int...
Dynamic Talks: "Applications of Big Data, Machine Learning and Artificial Int...
Grid Dynamics
 

What's hot (16)

Addressing the second 90: How can treatment scale-up across the European regi...
Addressing the second 90: How can treatment scale-up across the European regi...Addressing the second 90: How can treatment scale-up across the European regi...
Addressing the second 90: How can treatment scale-up across the European regi...
 
Priorities for fast tracking the end of AIDS in Europe: Community perspective
Priorities for fast tracking the end of AIDS in Europe: Community perspectivePriorities for fast tracking the end of AIDS in Europe: Community perspective
Priorities for fast tracking the end of AIDS in Europe: Community perspective
 
What is HIV epidemic control?
What is HIV epidemic control?What is HIV epidemic control?
What is HIV epidemic control?
 
Onile-ere et al 2016
Onile-ere et al 2016Onile-ere et al 2016
Onile-ere et al 2016
 
What is epidemic control after 2020 mwango 04082021
What is epidemic control after 2020 mwango 04082021What is epidemic control after 2020 mwango 04082021
What is epidemic control after 2020 mwango 04082021
 
01 viral load testing in zambia
01 viral load testing in zambia01 viral load testing in zambia
01 viral load testing in zambia
 
Bacterial Adaptive immunity, Gene drives and the genetic control of Malaria
Bacterial Adaptive immunity, Gene drives and the genetic control of MalariaBacterial Adaptive immunity, Gene drives and the genetic control of Malaria
Bacterial Adaptive immunity, Gene drives and the genetic control of Malaria
 
HIV self-testing and linkage in Africa
HIV self-testing and linkage in AfricaHIV self-testing and linkage in Africa
HIV self-testing and linkage in Africa
 
David curry
David curryDavid curry
David curry
 
APCRSHR10 Virtual Abstract Presentation of Dr Moazzam Ali
APCRSHR10 Virtual Abstract Presentation of Dr Moazzam AliAPCRSHR10 Virtual Abstract Presentation of Dr Moazzam Ali
APCRSHR10 Virtual Abstract Presentation of Dr Moazzam Ali
 
Reaching the Millennial Generation about HIV/AIDS
Reaching the Millennial Generation about HIV/AIDSReaching the Millennial Generation about HIV/AIDS
Reaching the Millennial Generation about HIV/AIDS
 
03 children's enhanced adherence couselling in zambia ss
03 children's enhanced adherence couselling in zambia ss03 children's enhanced adherence couselling in zambia ss
03 children's enhanced adherence couselling in zambia ss
 
Evaluation of the Impact of Malaria Control Interventions on All-Cause Mortal...
Evaluation of the Impact of Malaria Control Interventions on All-Cause Mortal...Evaluation of the Impact of Malaria Control Interventions on All-Cause Mortal...
Evaluation of the Impact of Malaria Control Interventions on All-Cause Mortal...
 
AIRAPertussisUTD_20150422
AIRAPertussisUTD_20150422AIRAPertussisUTD_20150422
AIRAPertussisUTD_20150422
 
02 efficacious arv regimens for children in zambia
02 efficacious arv regimens for children in zambia02 efficacious arv regimens for children in zambia
02 efficacious arv regimens for children in zambia
 
Dynamic Talks: "Applications of Big Data, Machine Learning and Artificial Int...
Dynamic Talks: "Applications of Big Data, Machine Learning and Artificial Int...Dynamic Talks: "Applications of Big Data, Machine Learning and Artificial Int...
Dynamic Talks: "Applications of Big Data, Machine Learning and Artificial Int...
 

Viewers also liked

PrEP delivery and controls
PrEP delivery and controlsPrEP delivery and controls
PrEP delivery and controls
ReShape
 
Common outcomes measurement framework
Common outcomes measurement frameworkCommon outcomes measurement framework
Common outcomes measurement framework
ReShape
 
Hepatitis C Research Gaps - Graham Cooke
Hepatitis C Research Gaps - Graham CookeHepatitis C Research Gaps - Graham Cooke
Hepatitis C Research Gaps - Graham Cooke
ReShape
 
ChemSex
ChemSexChemSex
ChemSex
ReShape
 
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
ReShape
 
ChemSex - Early Interventions Considerations
ChemSex - Early Interventions ConsiderationsChemSex - Early Interventions Considerations
ChemSex - Early Interventions Considerations
ReShape
 
PrEP and ChemSex: Looking forward
PrEP and ChemSex: Looking forwardPrEP and ChemSex: Looking forward
PrEP and ChemSex: Looking forward
ReShape
 
ChemSex across Germany - What's known and what's not
ChemSex across Germany - What's known and what's notChemSex across Germany - What's known and what's not
ChemSex across Germany - What's known and what's not
ReShape
 
The ChemSex phenomenon
The ChemSex phenomenonThe ChemSex phenomenon
The ChemSex phenomenon
ReShape
 
Towards a ChemSex map: Overview of data and evidence
Towards a ChemSex map: Overview of data and evidenceTowards a ChemSex map: Overview of data and evidence
Towards a ChemSex map: Overview of data and evidence
ReShape
 
ChemSex and Injecting
ChemSex and InjectingChemSex and Injecting
ChemSex and Injecting
ReShape
 
ChemSex in therapy
ChemSex in therapyChemSex in therapy
ChemSex in therapy
ReShape
 
ChemSex: a community policy response
ChemSex: a community policy responseChemSex: a community policy response
ChemSex: a community policy response
ReShape
 
ChemSex and Wellbeing Programme
ChemSex and Wellbeing ProgrammeChemSex and Wellbeing Programme
ChemSex and Wellbeing Programme
ReShape
 

Viewers also liked (14)

PrEP delivery and controls
PrEP delivery and controlsPrEP delivery and controls
PrEP delivery and controls
 
Common outcomes measurement framework
Common outcomes measurement frameworkCommon outcomes measurement framework
Common outcomes measurement framework
 
Hepatitis C Research Gaps - Graham Cooke
Hepatitis C Research Gaps - Graham CookeHepatitis C Research Gaps - Graham Cooke
Hepatitis C Research Gaps - Graham Cooke
 
ChemSex
ChemSexChemSex
ChemSex
 
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
 
ChemSex - Early Interventions Considerations
ChemSex - Early Interventions ConsiderationsChemSex - Early Interventions Considerations
ChemSex - Early Interventions Considerations
 
PrEP and ChemSex: Looking forward
PrEP and ChemSex: Looking forwardPrEP and ChemSex: Looking forward
PrEP and ChemSex: Looking forward
 
ChemSex across Germany - What's known and what's not
ChemSex across Germany - What's known and what's notChemSex across Germany - What's known and what's not
ChemSex across Germany - What's known and what's not
 
The ChemSex phenomenon
The ChemSex phenomenonThe ChemSex phenomenon
The ChemSex phenomenon
 
Towards a ChemSex map: Overview of data and evidence
Towards a ChemSex map: Overview of data and evidenceTowards a ChemSex map: Overview of data and evidence
Towards a ChemSex map: Overview of data and evidence
 
ChemSex and Injecting
ChemSex and InjectingChemSex and Injecting
ChemSex and Injecting
 
ChemSex in therapy
ChemSex in therapyChemSex in therapy
ChemSex in therapy
 
ChemSex: a community policy response
ChemSex: a community policy responseChemSex: a community policy response
ChemSex: a community policy response
 
ChemSex and Wellbeing Programme
ChemSex and Wellbeing ProgrammeChemSex and Wellbeing Programme
ChemSex and Wellbeing Programme
 

Similar to The HIV Cascade - Dr Laura Waters

Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
HopkinsCFAR
 
Shahin Lockman, Botswana: Arc of and Response to the HIV Epidemic
Shahin Lockman, Botswana: Arc of and Response to the HIV EpidemicShahin Lockman, Botswana: Arc of and Response to the HIV Epidemic
Shahin Lockman, Botswana: Arc of and Response to the HIV Epidemic
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics
 
2019-cde-ias-hepatitis-c-elimination.pdf
2019-cde-ias-hepatitis-c-elimination.pdf2019-cde-ias-hepatitis-c-elimination.pdf
2019-cde-ias-hepatitis-c-elimination.pdf
HajrahHajrah5
 
How are countries in Europe and Central Asia performing against the UNAIDS 90...
How are countries in Europe and Central Asia performing against the UNAIDS 90...How are countries in Europe and Central Asia performing against the UNAIDS 90...
How are countries in Europe and Central Asia performing against the UNAIDS 90...
European Centre for Disease Prevention and Control
 
Hepatitis C elimination in HIV-infected men who have sex with men: reality an...
Hepatitis C elimination in HIV-infected men who have sex with men: reality an...Hepatitis C elimination in HIV-infected men who have sex with men: reality an...
Hepatitis C elimination in HIV-infected men who have sex with men: reality an...
UC San Diego AntiViral Research Center
 
Regional Overview in HIV by Steve Kraus
Regional Overview in HIV by Steve KrausRegional Overview in HIV by Steve Kraus
Regional Overview in HIV by Steve Kraus
Dr. Rubz
 
Strategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in EuropeStrategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in Europe
European Centre for Disease Prevention and Control
 
What Works? – more than 30 years of prevention and control of HIV
What Works? – more than 30 years of prevention and control of HIVWhat Works? – more than 30 years of prevention and control of HIV
What Works? – more than 30 years of prevention and control of HIV
European Centre for Disease Prevention and Control
 
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
StopTb Italia
 
Dye Snell lecture BTS 7dec16 final
Dye Snell lecture BTS 7dec16 finalDye Snell lecture BTS 7dec16 final
Dye Snell lecture BTS 7dec16 final
Christopher Dye
 
RNTCP
RNTCPRNTCP
Global and Indian plan to End TB
Global and Indian plan to End TBGlobal and Indian plan to End TB
Global and Indian plan to End TB
Rama shankar
 
Can we end the HIV/AIDS epidemic? Josip begovac
Can we end the HIV/AIDS epidemic? Josip begovacCan we end the HIV/AIDS epidemic? Josip begovac
Can we end the HIV/AIDS epidemic? Josip begovac
PinHealth
 
Towards a world without AIDS
Towards a world without AIDSTowards a world without AIDS
Towards a world without AIDS
Dr.Mahmoud Abbas
 
Epidemiology Update: Disparities in the HIV Continuum of Care
Epidemiology Update: Disparities in the HIV Continuum of CareEpidemiology Update: Disparities in the HIV Continuum of Care
Epidemiology Update: Disparities in the HIV Continuum of Care
Office of HIV Planning
 
HPV INFECTIONS WITH RECENT ADVANCES IN CARCINOMA CERVIX.pptx
HPV INFECTIONS WITH RECENT ADVANCES IN CARCINOMA CERVIX.pptxHPV INFECTIONS WITH RECENT ADVANCES IN CARCINOMA CERVIX.pptx
HPV INFECTIONS WITH RECENT ADVANCES IN CARCINOMA CERVIX.pptx
akshatsahni425
 
Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?
European Centre for Disease Prevention and Control
 
Changing the Narrative for Women & Girls (Tx, Recovery)
Changing the Narrative for Women & Girls (Tx, Recovery)Changing the Narrative for Women & Girls (Tx, Recovery)
Changing the Narrative for Women & Girls (Tx, Recovery)
Alton King
 
nationalaidscontrolprogrammenacp-210419063636.pdf
nationalaidscontrolprogrammenacp-210419063636.pdfnationalaidscontrolprogrammenacp-210419063636.pdf
nationalaidscontrolprogrammenacp-210419063636.pdf
ssuserd6cc4b
 
National AIDS Control Programme NACP
National AIDS Control Programme NACPNational AIDS Control Programme NACP
National AIDS Control Programme NACP
Harsh Rastogi
 

Similar to The HIV Cascade - Dr Laura Waters (20)

Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
 
Shahin Lockman, Botswana: Arc of and Response to the HIV Epidemic
Shahin Lockman, Botswana: Arc of and Response to the HIV EpidemicShahin Lockman, Botswana: Arc of and Response to the HIV Epidemic
Shahin Lockman, Botswana: Arc of and Response to the HIV Epidemic
 
2019-cde-ias-hepatitis-c-elimination.pdf
2019-cde-ias-hepatitis-c-elimination.pdf2019-cde-ias-hepatitis-c-elimination.pdf
2019-cde-ias-hepatitis-c-elimination.pdf
 
How are countries in Europe and Central Asia performing against the UNAIDS 90...
How are countries in Europe and Central Asia performing against the UNAIDS 90...How are countries in Europe and Central Asia performing against the UNAIDS 90...
How are countries in Europe and Central Asia performing against the UNAIDS 90...
 
Hepatitis C elimination in HIV-infected men who have sex with men: reality an...
Hepatitis C elimination in HIV-infected men who have sex with men: reality an...Hepatitis C elimination in HIV-infected men who have sex with men: reality an...
Hepatitis C elimination in HIV-infected men who have sex with men: reality an...
 
Regional Overview in HIV by Steve Kraus
Regional Overview in HIV by Steve KrausRegional Overview in HIV by Steve Kraus
Regional Overview in HIV by Steve Kraus
 
Strategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in EuropeStrategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in Europe
 
What Works? – more than 30 years of prevention and control of HIV
What Works? – more than 30 years of prevention and control of HIVWhat Works? – more than 30 years of prevention and control of HIV
What Works? – more than 30 years of prevention and control of HIV
 
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
 
Dye Snell lecture BTS 7dec16 final
Dye Snell lecture BTS 7dec16 finalDye Snell lecture BTS 7dec16 final
Dye Snell lecture BTS 7dec16 final
 
RNTCP
RNTCPRNTCP
RNTCP
 
Global and Indian plan to End TB
Global and Indian plan to End TBGlobal and Indian plan to End TB
Global and Indian plan to End TB
 
Can we end the HIV/AIDS epidemic? Josip begovac
Can we end the HIV/AIDS epidemic? Josip begovacCan we end the HIV/AIDS epidemic? Josip begovac
Can we end the HIV/AIDS epidemic? Josip begovac
 
Towards a world without AIDS
Towards a world without AIDSTowards a world without AIDS
Towards a world without AIDS
 
Epidemiology Update: Disparities in the HIV Continuum of Care
Epidemiology Update: Disparities in the HIV Continuum of CareEpidemiology Update: Disparities in the HIV Continuum of Care
Epidemiology Update: Disparities in the HIV Continuum of Care
 
HPV INFECTIONS WITH RECENT ADVANCES IN CARCINOMA CERVIX.pptx
HPV INFECTIONS WITH RECENT ADVANCES IN CARCINOMA CERVIX.pptxHPV INFECTIONS WITH RECENT ADVANCES IN CARCINOMA CERVIX.pptx
HPV INFECTIONS WITH RECENT ADVANCES IN CARCINOMA CERVIX.pptx
 
Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?
 
Changing the Narrative for Women & Girls (Tx, Recovery)
Changing the Narrative for Women & Girls (Tx, Recovery)Changing the Narrative for Women & Girls (Tx, Recovery)
Changing the Narrative for Women & Girls (Tx, Recovery)
 
nationalaidscontrolprogrammenacp-210419063636.pdf
nationalaidscontrolprogrammenacp-210419063636.pdfnationalaidscontrolprogrammenacp-210419063636.pdf
nationalaidscontrolprogrammenacp-210419063636.pdf
 
National AIDS Control Programme NACP
National AIDS Control Programme NACPNational AIDS Control Programme NACP
National AIDS Control Programme NACP
 

More from ReShape

European ChemSex forum report 2018
European ChemSex forum report 2018European ChemSex forum report 2018
European ChemSex forum report 2018
ReShape
 
Where's the hope? Dialogues for Solidarity - Session 4
Where's the hope? Dialogues for Solidarity - Session 4Where's the hope? Dialogues for Solidarity - Session 4
Where's the hope? Dialogues for Solidarity - Session 4
ReShape
 
Where's the hope? Dialogues for solidarity, Session 3
Where's the hope? Dialogues for solidarity, Session 3Where's the hope? Dialogues for solidarity, Session 3
Where's the hope? Dialogues for solidarity, Session 3
ReShape
 
Where's the Hope? Dialogues for Solidarity, Session 2
Where's the Hope? Dialogues for Solidarity, Session 2Where's the Hope? Dialogues for Solidarity, Session 2
Where's the Hope? Dialogues for Solidarity, Session 2
ReShape
 
Where's the hope? Dialogues for Solidarity - Session 1
Where's the hope? Dialogues for Solidarity - Session 1Where's the hope? Dialogues for Solidarity - Session 1
Where's the hope? Dialogues for Solidarity - Session 1
ReShape
 
HCV Treatment Access across Europe - Raquel Peck
HCV Treatment Access across Europe - Raquel PeckHCV Treatment Access across Europe - Raquel Peck
HCV Treatment Access across Europe - Raquel Peck
ReShape
 
New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...
New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...
New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...
ReShape
 
Hepatitis C Generic Drugs - Stuart Flanagan
Hepatitis C Generic Drugs - Stuart FlanaganHepatitis C Generic Drugs - Stuart Flanagan
Hepatitis C Generic Drugs - Stuart Flanagan
ReShape
 
European ChemSex Forum Report
European ChemSex Forum ReportEuropean ChemSex Forum Report
European ChemSex Forum Report
ReShape
 
G monitor sheet
G monitor sheetG monitor sheet
G monitor sheet
ReShape
 
Outreach and community engagement. Supporting & resourcing the gay community ...
Outreach and community engagement. Supporting & resourcing the gay community ...Outreach and community engagement. Supporting & resourcing the gay community ...
Outreach and community engagement. Supporting & resourcing the gay community ...
ReShape
 
Consent & Responsibility: a UK Perspective
Consent & Responsibility: a UK PerspectiveConsent & Responsibility: a UK Perspective
Consent & Responsibility: a UK Perspective
ReShape
 
Siegfried Schwarze
Siegfried Schwarze Siegfried Schwarze
Siegfried Schwarze
ReShape
 
Psychosexual issues and ChemSex
Psychosexual issues and ChemSexPsychosexual issues and ChemSex
Psychosexual issues and ChemSex
ReShape
 
Club Drug Clinic, Project Neptune and the G Trial
Club Drug Clinic, Project Neptune and the G TrialClub Drug Clinic, Project Neptune and the G Trial
Club Drug Clinic, Project Neptune and the G Trial
ReShape
 
Sexual health interventions: prescribing, screening, risk assessments
Sexual health interventions: prescribing, screening, risk assessmentsSexual health interventions: prescribing, screening, risk assessments
Sexual health interventions: prescribing, screening, risk assessments
ReShape
 
Co-infection Linkages
Co-infection LinkagesCo-infection Linkages
Co-infection Linkages
ReShape
 
CHECKOUT - Anonymous partner notification
CHECKOUT - Anonymous partner notificationCHECKOUT - Anonymous partner notification
CHECKOUT - Anonymous partner notification
ReShape
 

More from ReShape (18)

European ChemSex forum report 2018
European ChemSex forum report 2018European ChemSex forum report 2018
European ChemSex forum report 2018
 
Where's the hope? Dialogues for Solidarity - Session 4
Where's the hope? Dialogues for Solidarity - Session 4Where's the hope? Dialogues for Solidarity - Session 4
Where's the hope? Dialogues for Solidarity - Session 4
 
Where's the hope? Dialogues for solidarity, Session 3
Where's the hope? Dialogues for solidarity, Session 3Where's the hope? Dialogues for solidarity, Session 3
Where's the hope? Dialogues for solidarity, Session 3
 
Where's the Hope? Dialogues for Solidarity, Session 2
Where's the Hope? Dialogues for Solidarity, Session 2Where's the Hope? Dialogues for Solidarity, Session 2
Where's the Hope? Dialogues for Solidarity, Session 2
 
Where's the hope? Dialogues for Solidarity - Session 1
Where's the hope? Dialogues for Solidarity - Session 1Where's the hope? Dialogues for Solidarity - Session 1
Where's the hope? Dialogues for Solidarity - Session 1
 
HCV Treatment Access across Europe - Raquel Peck
HCV Treatment Access across Europe - Raquel PeckHCV Treatment Access across Europe - Raquel Peck
HCV Treatment Access across Europe - Raquel Peck
 
New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...
New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...
New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...
 
Hepatitis C Generic Drugs - Stuart Flanagan
Hepatitis C Generic Drugs - Stuart FlanaganHepatitis C Generic Drugs - Stuart Flanagan
Hepatitis C Generic Drugs - Stuart Flanagan
 
European ChemSex Forum Report
European ChemSex Forum ReportEuropean ChemSex Forum Report
European ChemSex Forum Report
 
G monitor sheet
G monitor sheetG monitor sheet
G monitor sheet
 
Outreach and community engagement. Supporting & resourcing the gay community ...
Outreach and community engagement. Supporting & resourcing the gay community ...Outreach and community engagement. Supporting & resourcing the gay community ...
Outreach and community engagement. Supporting & resourcing the gay community ...
 
Consent & Responsibility: a UK Perspective
Consent & Responsibility: a UK PerspectiveConsent & Responsibility: a UK Perspective
Consent & Responsibility: a UK Perspective
 
Siegfried Schwarze
Siegfried Schwarze Siegfried Schwarze
Siegfried Schwarze
 
Psychosexual issues and ChemSex
Psychosexual issues and ChemSexPsychosexual issues and ChemSex
Psychosexual issues and ChemSex
 
Club Drug Clinic, Project Neptune and the G Trial
Club Drug Clinic, Project Neptune and the G TrialClub Drug Clinic, Project Neptune and the G Trial
Club Drug Clinic, Project Neptune and the G Trial
 
Sexual health interventions: prescribing, screening, risk assessments
Sexual health interventions: prescribing, screening, risk assessmentsSexual health interventions: prescribing, screening, risk assessments
Sexual health interventions: prescribing, screening, risk assessments
 
Co-infection Linkages
Co-infection LinkagesCo-infection Linkages
Co-infection Linkages
 
CHECKOUT - Anonymous partner notification
CHECKOUT - Anonymous partner notificationCHECKOUT - Anonymous partner notification
CHECKOUT - Anonymous partner notification
 

Recently uploaded

K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
ZayedKhan38
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
Gokuldas Hospital
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 

Recently uploaded (20)

K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 

The HIV Cascade - Dr Laura Waters

  • 1. The HIV cascade Laura Waters Mortimer Market Centre CNWL NHS Trust
  • 2. What are cascades? • A broad overview of how well a given condition is managed • Trials and many observational studies focus on treatment outcomes, excluding those untreated or undiagnosed • “95% of people treated for condition X had good outcomes” • Cascades show the whole picture and where the gaps are….
  • 3. Cascade of care for condition X 60% 58% 56% 50% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% With condition Diagnosed In care Treated Optimally treated 100%
  • 4. Cascade of care for condition Y 90% 50% 40% 35% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% With condition Diagnosed In care Treated Optimally treated 100%
  • 5. UK cascade of HIV care 2014 83% 75% 70% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% HIV-infected Diagnosed On ART Undetectable VL Based on 1.2 million people living with HIV Delpech V at al. Abstract O2; BHIVA conference April 20-22 2016.
  • 6. USA: continuum of care 2011 86% 40% 37% 30% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Diagnosed In care Prescribed ART Virally suppressed https://www.aids.gov/federal-resources/policies/care-continuum/ Based on 1.2 million people living with HIV
  • 7. USA cascade of hypertension: 69.8m of 227.6m hypertensive 94% 78% 73% 50% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Hypertensive Source of care Aware Treated Controlled 100% Wozniak G et al. J Clin Hypertens (Greenwich). 2016 Mar;18(3):232-9.
  • 8. Cascades can also be…. • Aspirational! • The basis of public health interventions….
  • 9.
  • 10. What is 90-90-90? • December 2013: – The UNAIDS Programme Coordinating Board called on UNAIDS to establish new targets for HIV treatment scale- up beyond 2015 • The following goals were agreed in 2014: – By 2020, 90% of all people living with HIV will know their HIV status. – By 2020, 90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy. – By 2020, 90% of all people receiving antiretroviral therapy will have viral suppression.
  • 12. What does that mean? • 73% of all PLWH on suppressive ART would be a 2-3 fold increase compared with 2014 estimates • Modelling suggests that achieving these targets by 2020 will end the AIDS epidemic by 2030
  • 13. Ref: The Joint United Nations Programme on HIV/AIDS. 90-90-90 An ambitious treatment target to help end the AIDS epidemic. 2014; JC2684 (Numbers as of March 2015) How Aids Changed Everything. Fact Sheet. UNAIDS 2015. MDG 6: 15 YEARS, 15 LESSONS OF HOPE FROM THE AIDS RESPONSE July 2015. Target 1: 90% of HIV+ people diagnosed Target 2: 90% of diagnosed people on ART Target 3: 90% of people on ART with HIV RNA suppression90% 81% 73% 0% 20% 40% 60% 80% 100% HIV Positive People Diagnosed On ART Viral Suppression 36.9 million 33.2 million 29.5 million 26.9 million UNAIDS 90-90-90: HIV Treatment Targets for 2020 with Global Estimates (2014)
  • 14. 53% 41% 32%* 0% 20% 40% 60% 80% 100% HIV Positive People Diagnosed On ART Viral Suppression <1000 (ITT)* 36.9 million 19.8 million 15.0 million 11.6* million Ref: On ART = March 2015. How Aids Changed Everything. Fact Sheet. UNAIDS 2015. MDG 6: 15 YEARS, 15 LESSONS OF HOPE FROM THE AIDS RESPONSE July 2015. * Average viral suppression% Intention to Treat LMIC rate from a Systematic Review by McMahon J. et al. Viral suppression after 12 months of antiretroviral therapy in low-and middle-income countries: a systematic review." Bulletin of the World Health Organization 91.5 (2013): 377-385. Breakpoint 1: 13.4 million Undiagnosed Breakpoint 2: 14.9 million not treated Breakpoint 3: 15.3 million Not Virally Supressed Global Estimates (2014-15) vs the Gap to reach 90-90-90 Targets
  • 15. UNAIDS: 90-90-90 90%90% 90% 90% 90% UNAIDS. 90–90–90: an ambitious treatment target to help end the AIDS epidemic. 2014. http://www.unaids.org/sites/default/files/media_asset/90-90-90_en_0.pdf. Accessed 29th June 2016 Diagnosed On treatment Undetectable What about those on ART & ‘stable’?? ?
  • 16. May 2016: World Health Assembly’s 69th session • Approved a new Global Health Sector Strategy on HIV for 2016–2021 • Goal is “to end the AIDS epidemic as a public health threat by 2030” “zero new HIV infections, zero HIV-related deaths and zero HIV- related discrimination in a world where people living with HIV are able to live long and healthy lives” “to end the AIDS epidemic as a public health threat by 2030, within the context of ensuring healthy lives and promoting well-being for all at all ages” World Health Organization. Draft global health sector strategy on HIV, 2016–2021 [Draft 01.12.2015]. 2015. http://apps.who.int/gb/ebwha/pdf_files/WHA69/A69_31-en.pdf?ua=1. Acceessed 29th June 2016
  • 17. UNAIDS: 90-90-90-90? 90%90% 90% 90% 90% 90% Lazarus JV et al. BMC Med. 2016; 14: 94. Adapted from UNAIDS. 90–90–90: an ambitious treatment target to help end the AIDS epidemic. 2014. http://www.unaids.org/sites/default/files/media_asset/90-90-90_en_0.pdf. Accessed 29th June 2016 Diagnosed On treatment Undetectable Good health- related QoL

Editor's Notes

  1. Reasons for non suppression: 66% diagnosed but not in care, 20% undiagnosed, 10% on ART but not suppressed, 4% in care but not on ART
  2. Reasons for non suppression: 66% diagnosed but not in care, 20% undiagnosed, 10% on ART but not suppressed, 4% in care but not on ART
  3. Reasons for non suppression: 66% diagnosed but not in care, 20% undiagnosed, 10% on ART but not suppressed, 4% in care but not on ART
  4. In 2014 UNAIDS set 3 ambitious targets to increase global coverage of HIV care by the year 2020   These are: Target 1 - 90% of all people living with HIV to be diagnosed   Target 2 - 90% of those diagnosed to receive antiretroviral treatment   And Target 3 - 90% of all of those on treatment to achieve viral suppression   This means that in the final category, 73% of all HIV positive people should be achieving viral suppression by 2020.   The numbers here in white show how many people should be in each category, given that nearly 37 million people are estimated to be living with HIV globally. http://www.unaids.org/sites/default/files/media_asset/JC2702_GARPR2015guidelines_en.pdf
  5. Using the most recent data from UNAIDS, and a systematic review on viral suppression rates by Mcmahon et al, this global cascade estimates where we are currently compared to the targets.   Just over half of all HIV + people know their status and 41% (about 15 million) are on treatment as of March 2015. The numbers in white show the most current estimates for the number of people in each category worldwide.   Where the targets are not yet reached – red arrows illustrate the gaps in the cascade – This is where we are missing the targets and we will define these as breakpoints.   Can these UNAIDS 90-90-90 target be reached? … (Pause) July 2014 – 13,950,296 http://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2014/july/20140716prgapreport
  6. Good health related QoL: Two domains: Co-morbidities Self-perceived quality of life